Literature DB >> 23903505

Clinicopathological analysis of glomerulopathy with fibronectin deposits (GFND): a case of sporadic, elderly-onset GFND with codeposition of IgA, C1q, and fibrinogen.

Masabumi Yoshino1, Naoto Miura, Takahiro Ohnishi, Keisuke Suzuki, Wataru Kitagawa, Kazuhiro Nishikawa, Hirokazu Imai.   

Abstract

A 67-year-old Japanese man with recurrent nephrotic syndrome and impaired kidney function had a sporadic, elderly-onset case of glomerulopathy with fibronectin deposits. The daily urinary protein, serum albumin, blood urea nitrogen, and creatinine levels were 3.6 g/day, 2.7 g/dL, 19.5 mg/dL, and 1.70 mg/dL, respectively. Kidney biopsy samples were evaluated using electron microscopy and demonstrated membranoproliferative glomerulonephritis-like lesions with massive subendothelial depositions and no fibrillary structures. Immunofluorescent studies showed 1+ staining for IgA, C1q, and fibrinogen. Anti-fibronectin immunostaining demonstrated that the subendothelial deposits were positive for fibronectin. The administration of prednisolone and mizoribine improved the nephrotic syndrome.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23903505     DOI: 10.2169/internalmedicine.52.0046

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  8 in total

Review 1.  Pathogenesis of glomerular haematuria.

Authors:  Claudia Yuste; Eduardo Gutierrez; Angel Manuel Sevillano; Alfonso Rubio-Navarro; Juan Manuel Amaro-Villalobos; Alberto Ortiz; Jesus Egido; Manuel Praga; Juan Antonio Moreno
Journal:  World J Nephrol       Date:  2015-05-06

Review 2.  Haematuria as a risk factor for chronic kidney disease progression in glomerular diseases: A review.

Authors:  Juan Antonio Moreno; Claudia Yuste; Eduardo Gutiérrez; Ángel M Sevillano; Alfonso Rubio-Navarro; Juan Manuel Amaro-Villalobos; Manuel Praga; Jesús Egido
Journal:  Pediatr Nephrol       Date:  2015-05-17       Impact factor: 3.714

3.  Prednisone-induced sustained remission in a patient with familial fibronectin glomerulopathy (GFND).

Authors:  Bruce I Goldman; Bernard J Panner; Stephen L Welle; Matthew D Gross; Daniel A Gray
Journal:  CEN Case Rep       Date:  2021-04-10

4.  Bortezomib-containing regiment in treating glomerulopathy with fibronectin deposits combined with monoclonal gammopathy of undetermined significance: a case report and literature review.

Authors:  Wenjie Zhang; Qike Zhang; Xiaofang Wei; Youfan Feng
Journal:  Ann Transl Med       Date:  2022-03

5.  A Case of Fibronectin Glomerulopathy Caused by Missense Mutations in the Fibronectin 1 Gene.

Authors:  Shuma Hirashio; Yumi Yamada; Kouichi Mandai; Shigeo Hara; Takao Masaki
Journal:  Kidney Int Rep       Date:  2017-03-01

Review 6.  Fibronectin glomerulopathy complicated with persistent cloaca and congenital esophageal atresia: a case report and literature review.

Authors:  Misaki Takii; Takaichi Suehiro; Aya Shima; Hideki Yotsueda; Satoshi Hisano; Ritsuko Katafuchi
Journal:  BMC Nephrol       Date:  2017-09-06       Impact factor: 2.388

7.  A novel single amino acid deletion impairs fibronectin function and causes familial glomerulopathy with fibronectin deposits: case report of a family.

Authors:  Maria Luíza Gonçalves Dos Reis Monteiro; Fabiano Bichuette Custódio; Precil Diego Miranda de Menezes Neves; Frederico Moraes Ferreira; Elieser Hitoshi Watanabe; Antônio Marcondes Lerário; Liliane Silvano de Araújo; Bruno Eduardo Pedroso Balbo; Vívian Christine Dourado Pinto; Lívia Maria Gruli Barbosa; Vilmar de Paiva Marques; Juliana Reis Machado; Marlene Antônia Reis; Luiz Fernando Onuchic
Journal:  BMC Nephrol       Date:  2019-08-16       Impact factor: 2.388

8.  A child with genetic FN1 mutation in the absence of classic glomerulopathy with fibronectin deposits(GFND) findings on biopsy.

Authors:  Xiao-Qing Yang; Tong Shen
Journal:  BMC Nephrol       Date:  2022-07-14       Impact factor: 2.585

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.